Cooperative Agreement NU2GGH001650

This Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283) provides $8,536,000.00 to the African Field Epidemiology Network LTD (AFENET) to reinforce immunization systems in the Democratic Republic of Congo, Ethiopia, and Nigeria over a 5-year period from Sep 30, 2024 to Sep 29, 2029. The key products and services to be delivered include strengthening...

This $300,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program supports the "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA" project implemented by Humana People To People Congo (HPP-Congo) in Kinshasa, Democratic Republic of the Congo. The project aims to strengthen systematic, people-centered approaches to HIV/TB prevention, detection, and treatment, while improving clinical and community-based services...

The United States Agency for International Development (USAID) Bureau for Global Health awarded a cooperative agreement totaling $78,980,821 to DAI Global LLC, doing business as DAI, to improve the capacity of countries in high-risk areas to respond to outbreaks of emergent zoonotic diseases in Uganda. The purpose of this agreement was to enhance Uganda's ability to detect and respond to zoonotic disease outbreaks from 2009 to 2014 through USAID's Foreign Assistance for Programs Overseas...

The Centers for Disease Control and Prevention (CDC) awarded a $600,000 Cooperative Agreement under the CDC Investigations and Technical Assistance program (CFDA 93.283) to Jhpiego Corp, a non-profit global health organization. The award, titled "Achieving Global Health Security Through Strengthening Public Health Emergency Preparedness and Management Platforms in Liberia," aims to strengthen public health emergency preparedness and management capabilities in Liberia. The 5-year...

This Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $11,097,080 to Global Health Systems Solutions (GHSS) to build and improve integrated laboratory capacity and quality services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB sites; 2) expand quality testing for viral load, early infant diagnosis,...

This Cooperative Agreement award for $1,062,500.00, funded by the National Science Foundation under the Biological Sciences (CFDA 47.074) program, supports the "Pandemic Environmental Surveillance Center for Assessing Pathogen Emergence (Pandemic ESCAPE)". The goal of this project is to advance environmental surveillance (ES) technology, data interpretation, and adoption to enable the timely detection of emerging pathogens across diverse settings. Key activities include research and...

This $2,777,976 Cooperative Agreement, awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program, aims to improve the response to HIV and ensure sustained epidemic control in targeted areas of the Democratic Republic of Congo (DRC). The primary awardee, Family Health International (FHI 360), will implement activities to decrease new HIV infections and reduce HIV-associated morbidity and mortality in the...

This $3,069,819 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports Sante Espoir Vie Cote D'Ivoire (SEV-CI), a non-profit organization, to provide technical assistance to the Ministry of Health of Cote d'Ivoire. The project aims to strengthen the capacity of the national and decentralized health system to deliver comprehensive HIV prevention, care, and treatment services and achieve the UNAIDS 95-95-95...

This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

This federal Cooperative Agreement award of $19,252,877 from the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 "Centers for Disease Control and Prevention Investigations and Technical Assistance" program aims to implement evidence-based technical and science support services (TSSS) for HIV prevention, care, and treatment services in Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR). The key goals are to enhance Rwanda's public health response...